Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience. [PDF]
Bekircan-Kurt CE+16 more
europepmc +1 more source
Respiratory outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy: national real-world cohort study. [PDF]
Lavie M+10 more
europepmc +1 more source
Spinal presentations in children with type 1 spinal muscular atrophy on nusinersen treatment across the SMA-REACH UK network: a retrospective national observational study. [PDF]
Abbott L+9 more
europepmc +1 more source
Pediatric non-Hodgkin lymphoma as a rare cause of spinal cord injury: When lymphoma hides in the canal. [PDF]
Zama D+7 more
europepmc +1 more source
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies. [PDF]
Alves BKAMF+3 more
europepmc +1 more source
Abnormal expression of myosin heavy chains in early postnatal stages of spinal muscular atrophy type I at single fibre level. [PDF]
Hedberg-Oldfors C+3 more
europepmc +1 more source
Spinal adhesive arachnoiditis in an adult patient with spinal muscular atrophy type 3 treated with intrathecal therapy. [PDF]
Ubysz J+3 more
europepmc +1 more source
A reassessment of spinal cord pathology in severe infantile spinal muscular atrophy: Reassessment of spinal cord pathology. [PDF]
Allardyce H+4 more
europepmc +1 more source
Brain magnetic resonance imaging of patients with spinal muscular atrophy type 2 and 3. [PDF]
Stam M+6 more
europepmc +1 more source